Loading...
Anti-programmed death receptor 1 immunotherapy in melanoma: rationale, evidence and clinical potential
Malignant melanoma is a significant public health problem; according to 2013 Surveillance, Epidemiology, and End Results data, its average incidence rate rose 2.6% each year for the last decade, and it is now the fifth most common cancer diagnosis in the United States. The rising incidence and histo...
Na minha lista:
| Udgivet i: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SAGE Publications
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4265090/ https://ncbi.nlm.nih.gov/pubmed/25553080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834014551747 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|